Global Narcolepsy Drugs Market Overview 2023-2028
IMARC Group, a leading market research company, has recently releases report titled “Narcolepsy Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global Narcolepsy Drugs market report, share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
The global narcolepsy drugs market size reached US$ 3.1 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 4.8 Billion by 2028, exhibiting a growth rate (CAGR) of 7.51% during 2023-2028.
Narcolepsy medications refer to pharmaceutical substances prescribed for the management and alleviation of narcolepsy symptoms. These drugs act on neurotransmitters and neural pathways that regulate sleep-wake cycles. They can be administered through various routes, including oral and intranasal, depending on the specific medication and symptoms. Their primary function is to mitigate excessive daytime sleepiness, promoting alertness and wakefulness during the day. Furthermore, they aid in achieving a more consistent and restorative night's sleep. By establishing a foundational control over symptoms, these medications enhance the effectiveness of other therapeutic approaches. Additionally, the rising demand for narcolepsy medications globally can be attributed to their positive impact on overall mental well-being.
Global Narcolepsy Drugs Market Trends and Drivers:
The rise and growth of hospitals, clinics, online pharmacies, and telemedicine services are contributing to the increased availability and ease of access to narcolepsy treatments. Moreover, the trend toward personalized medicine and precise treatment plans based on individual patient profiles is shaping a promising market outlook. Technological advancements in drug formulation and delivery systems are also driving the market by offering more efficient and convenient treatment options. In addition, ongoing investments in research and development (R&D) by pharmaceutical companies aimed at creating innovative therapies and enhancing existing drugs are fueling market expansion. Additionally, strategic partnerships and collaborations between research institutions, biotech firms, and pharmaceutical companies to advance the development and commercialization of new narcolepsy drugs are positively impacting the market.
Global Narcolepsy Drugs Market 2023-2028 Analysis and Segmentation:
Top Key Players covered in this report are: Avadel Pharmaceuticals plc, Axsome Therapeutics Inc., Bioprojet Pharma, Graymark Healthcare Inc., Jazz Pharmaceuticals plc, Ligand Pharmaceuticals Incorporated, Novartis AG, SHIONOGI & Co. Ltd., Takeda Pharmaceutical Company Limited and Teva Pharmaceutical Industries Ltd.
The report segmented the market on the basis of region, type, disease type and therapeutic type.
Breakup by Type:
- Narcolepsy with Cataplexy
- Narcolepsy without Cataplexy
- Secondary Narcolepsy
Breakup by Disease Type:
- Daytime Extreme Sleepiness
- Cataplexia
- Others
Breakup by Therapeutic Type:
- Sodium Oxybate
- Central Nervous System Stimulants
- Tricyclic Antidepressants
- Selective Serotonin Reuptake Inhibitor
- Others
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Key highlights of the report:
- Market Performance (2017-2022)
- Market Outlook (2023- 2028)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Services Private Limited.
134 N 4th St. Brooklyn, NY 11249, USA
Email: [email protected]
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
